Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Thyroid Function Test Market Outlook from 2023 to 2033

The thyroid function test market is valued at US$ 1.75 billion in 2023. The thyroid function test market is expected to reach US$ 2.64 billion by 2033. Thyroid function test market revenue will continue to expand at a CAGR of 4.2%.

Thyroid Function Test Market Trends and Highlights

With thyroid disorders becoming more prevalent throughout the world, the thyroid function test market has grown steadily over the years. Changes in lifestyle, hormonal imbalances, and the growing incidence of thyroid disease among young people have contributed to the development of thyroid disease. According to the World Obesity Atlas 2023, there will be 3,041 million overweight or obese people in 2025.

Key Thyroid Function Test Market Trends

  • Hypothyroidism, hyperthyroidism, and other thyroid disorders are becoming increasingly common, increasing the number of thyroid function tests being performed.
  • Various lifestyle changes, factors related to the environment, and greater awareness have all played a role in this trend.
  • Technologies in thyroid function testing have advanced, resulting in more sensitive, accurate assays.
  • Thyroid disorders can now be diagnosed early and monitored in the early stages through these advancements.
  • Devices that facilitate rapid and convenient thyroid function testing at the point of care have become increasingly popular.
  • In recent years, these devices have become more sophisticated and user-friendly.
  • Thyroid cancer has increased in incidence, which makes it more important to differentiate benign thyroid nodules from malignant thyroid nodules.
  • The use of molecular diagnostics and fine needle aspiration techniques (FNA) played an integral role throughout the study.
Attributes Key Insights
Thyroid Function Test Market Estimated Size in 2023 US$ 1.75 billion
Projected Market Value in 2033 US$ 2.64 billion
Value-based CAGR from 2023 to 2033 4.2%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Historical Analysis vs. 2023 to 2033 Market Forecast Projections

Several studies indicated that the market was valued at US$ 2.54 billion by 2022, according to FMI. The global demand for thyroid function tests is expected to increase at a CAGR of 4.2% from 2023 to 2033.

TSH testing became an integral part of thyroid function testing, increasing the efficiency of disease screening, detecting hypothyroidism and hyperthyroidism in subclinical forms, and identifying treatments based on biochemical targets.

Historical CAGR from 2018 to 2022 3.9%
Forecast CAGR from 2023 to 2033 4.2%

As new diagnostic technologies to detect TSH hormones are developed, the market growth will be accelerated. The ongoing research on thyroid function and its relationship with metabolic disorders, cancers, autoimmune diseases, and metabolic disorders presents new therapeutic and diagnostic opportunities.

Companies complying with international standards and obtaining regulatory approval can be a barrier to market entry, but it can also be a means of establishing credibility and market presence. Thyroid disorders and their symptoms are not well known to many people. A campaign aimed at educating patients and raising awareness can drive thyroid function test adoption.

Thyroid Function Test Market Drivers

  • An increase in thyroid disorder incidences, sedentary lifestyles, and tobacco consumption are factors contributing to market growth. Over the past few decades, thyroid diseases have become a significant concern for public health.
  • Various government investments and sponsored clinical trials by major universities are expected to accelerate market growth.
  • With technological advances, thyroid function tests have become more accurate and efficient.
  • With new tests and diagnostic tools, measurements get faster and more precise, making testing more accessible and reliable.
  • The prevalence of thyroid disorders has increased, as well as awareness about the importance of early detection. Public health campaigns have promoted testing and boosted market growth and screening programs.
  • As part of routine health checkups, thyroid function tests are now included by many healthcare providers. Increasing testing frequency and increasing market growth have resulted from these integrations into primary care.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Thyroid Function Test Market Restraints

  • Thyroid function tests and thyroid disorder symptoms may be unknown to many individuals. Delays in diagnosis and testing can be caused by a lack of awareness. Certain regions or underserved populations may not have access to healthcare services, such as thyroid function tests. As a result, the growth potential of the market may be hindered.
  • Many people lack access to affordable thyroid function testing due to their financial situation. Tests can be expensive, which discourages people from getting them. Thyroid function tests may face competition from alternative methods such as ultrasounds and clinical examinations in the future.
  • Thyroid function tests fall under strict regulatory oversight in the market for medical diagnostics. Thyroid function test manufacturers may spend a lot of time and money navigating these regulations and obtaining necessary approvals.

Comparative View of Adjacent Markets

Future Market Insights has compared two other markets, namely the papillary thyroid cancer and the differentiated thyroid cancer therapeutics market below. The thyroid function test market size is projected to dominate these two markets over the forecast period 2023 to 2033.

With the demand for home-based testing and the booming medical and healthcare industries, new markets will be created. With the launch of the thyroid function test, companies will be able to grow in new directions.

Thyroid Function Test Market:

CAGR from 2023 to 2033 4.2%
Market Value in 2033 US$ 2.64 Billion
Key Trends
  • Increasing incidences of thyroid disorders and technological advances are expected to drive market trends.
Opportunities
  • With changing lifestyles, an aging population and point-of-care testing, thyroid function tests are expected to see lucrative opportunities in demand.

Papillary Thyroid Cancer Market:

CAGR from 2023 to 2033 6.2%
Market Value in 2033 US$ 5.3 billion
Key Trends
  • The increase in government funding and increased awareness of cancer is expected to boost demand for the market.
Opportunities
  • Research and development activities are expected to increase along with clinical trials, offering lucrative opportunities for the market.

Differentiated Thyroid Cancer Therapeutics Market:

CAGR from 2023 to 2033 10%
Market Value in 2033 US$ 15 billion
Key Trends
  • Thyroid cancers are becoming more prevalent and drugs are being approved for treatment, increasing demand for differentiated thyroid cancer drugs.
Opportunities
  • Growing awareness about thyroid cancer treatment options and government initiatives to reduce healthcare burdens are providing lucrative market opportunities.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and India. The United States is expected to be a key player, registering a 3.5% CAGR until 2033, followed by the United Kingdom which is likely to register a 3.3% CAGR.

Forecast CAGRs from 2023 to 2033

Germany 2.8%
India 3.2%
United States 3.5%
China 3.1%
United Kingdom 3.3%

Rise in Obesity Issues to Drive Demand for Thyroid Function Test in the United States

According to the forecast, the United States is expected to hold a significant share of the market. The United States is likely to expand at a CAGR of 3.5% from 2023 to 2033. The government has funded various endocrinology studies and the rising prevalence of obesity issues among young generations is expected to lead the market.

Growing awareness about thyroid issues and early diagnostics is anticipated to drive the market. The development of new preventative treatments for thyroid disease will be influenced mainly by newborn screenings for hypothyroidism and new research on thyroid hormones.

Due to an increase in demand for cost-effective ways of detecting thyroid cancer and promising progress on Grave's disease, alternative techniques are crucial. Hyperthyroidism is an uncommon condition in the United States, with an incidence of between 20 and 50 per 100,000 people, according to a June 2021 publication in the National Library of Medicine.

Awareness of Thyroid Disease and Hereditary Diseases will Boost Demand for Thyroid Function Tests in India

The thyroid function test market is anticipated to rise at a CAGR of 3.2% over the next ten years. As government programs and discounts on various tests become more popular in India, demand is expected to grow.

Testing the thyroid gland's function and diagnosing thyroid diseases is common in India. Increasing disposable incomes and awareness of these diseases are expected to drive market demand for these tests. As the global population grows and genetic diseases become more prevalent, these tests in the market will grow.

The increasing demand for thyroid function tests for pregnancy is expected to drive the demand for these tests in these countries. INMAS, Delhi, India's Institutional Ethics Committee approved the study on 5th March 2004. Using radioimmunoassays, an Indian study found that serum T3 and T4 values were higher in the first half of pregnancy, but declined by the middle of the pregnancy.

Rising Healthcare Facilities and Population to fuel Thyroid Function Tests in China

From 2023 to 2033, China is predicted to expand at a 3.1% CAGR in the thyroid function tests landscape. Since China has such a large population, thyroid function tests may be necessary for a substantial proportion of its population.

Growing middle-class incomes and heightened awareness about healthcare in China are likely to increase demand for medical tests, including thyroid function tests, that are used to diagnose and treat thyroid conditions early. Several environmental factors are associated with thyroid disorders, including iodine deficiency or excess, which may contribute to an increase in demand for thyroid function tests in certain parts of China.

Depending on the area, urban and rural areas may have different demands for thyroid function tests. Increasing healthcare access and services has been a priority of the Chinese government, which could influence thyroid function tests' demand.

Rising Investment in Research and Development Activities to Drive Demand for Thyroid Function Tests in the Market

Market growth in the United Kingdom has been steadily increasing. A 3.3% CAGR is projected for the country between 2023 and 2033. The increased prevalence of thyroid disorders and autoimmune diseases will increase demand for this product in the market.

Medical infrastructure expansion and high device spending are expected to drive the market. In addition to a modern medical infrastructure, thyroid function tests are being rapidly adopted for monitoring, diagnosing, and treating thyroid disorders.

Research and development activities and the growth of diagnostic centers will increase demand in the coming years. The development of new preventive treatments for thyroid disorders, combined with the development of cost-effective thyroid cancer detection methods, is likely to boost revenues.

Innovative Test and Diagnosis Methods to Dominate Thyroid Function Test in Germany

According to projections, the thyroid function test market in Germany will expand by 2.8% CAGR from 2023 to 2033. As innovations and techniques emerge in this country, thyroid function tests will become more popular.

Certain populations in Germany may be recommended to undergo regular thyroid function testing based on specific screening programs or guidelines. It is anticipated that regulations governing these tests and an increase in demand for point-of-care systems in Germany will result in growth in the market in the near future.

Category-wise Insights

According to market forecasts, TSH is predicted to dominate until 2033, growing at a CAGR of 2.3%. Based on the end-use segment, diagnostic laboratories are expected to expand at a CAGR of 2.9% during the forecast period.

Category CAGR from 2023 to 2033
TSH 2.3%
Diagnostic Laboratories 2.9%

TSH Test to Fuel Growth in the Thyroid Function Test Market

Based on the test type, the TSH segment is expected to remain dominant through 2033. The market is expected to expand at 2.3% between 2023 and 2033.

Obese patients with high TSH levels have a higher chance of developing various thyroid diseases. TSH tests are routinely ordered as part of health checks and screenings, especially for those with thyroid disorders in their families.

According to an article published in Frontiers in October 2022, since obesity has a complex and bidirectional relationship with thyroid function, a large population with obesity was found to exhibit an upward trend in TSH levels in females with increasing degrees of obesity, as demonstrated by the study.

Increased efficiency of TSH tests in diagnosing hypothyroidism and measuring thyroid gland function in the next few years is also expected to substantially boost the growth of this market over the forecast period.

Diagnostic Laboratories with Thyroid Function Test-Based is Expected to Rise Demand.

Based on end-use, the diagnostic laboratories segment is expected to dominate all other end use in the near future. A growth rate of 2.9% is projected from 2023 to 2033.

A rise in thyroid function tests and the number of patients is expected to increase market demand for these tests. As diagnostic centres grow and expand in different regions, demand for thyroid function tests in diagnostic laboratories is expected to rise.

Thyroid dysfunction awareness campaigns, public healthcare investment, and growing awareness about thyroid dysfunction will drive the growth of this segment. As home-based testing becomes more common and online free consultations become more popular, these tests in the market are expected to grow in demand.

Competitive Landscape

Various thyroid function test companies have developed a competitive advantage in the market by acquiring, merging, forming partners, and expanding their product lines through a variety of growth strategies, including research and development, acquisitions, mergers, and partnerships.

  • In February 2023, Parkway Laboratories introduced a new test profile to their catalogue, the Thyroid Screen in Pregnancy (code: TSP). As with the thyroid screen basic profile (code: TS1), the new test profile components are the same as those in the trimester-specific reference interval.
  • In October 2023, Lassen Therapeutics presented the final results of preclinical studies on LASN01, for the treatment of Thyroid Eye Disease (TED), at the American Thyroid Association (ATA). A study with LASN01 showed that it suppressed TED orbital fibroblast proliferation and secretion of hyaluronan, in addition to showing anti-fibrotic activity. LASN01 has the potential to become a new therapeutic agent for TED based on these results.

Report Scope

Attributes Details
Estimated Market Size in 2023 US$ 1.75 billion
Projected Market Valuation in 2033 US$ 2.64 billion
Value-based CAGR 2023 to 2033 4.2%
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis Value in US$ billion
Key Regions Covered
  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East & Africa
Key Market Segments Covered
  • Test Type
  • End Use
  • Region
Key Countries Profiled
  • The United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • The United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • Poland
  • Czech Republic
  • Romania
  • India
  • Bangladesh
  • Australia
  • New Zealand
  • China
  • Japan
  • South Korea
  • GCC countries
  • South Africa
  • Israel
Key Companies Profiled
  • Danaher Corporation
  • DiaSorin
  • F.Hoffmann-La Roche AG
  • Merck KGaA
  • Biomerieux
  • Abbott Laboratories
  • ThermoFisher Scientific
  • Qualigen Inc.
  • KRONUS
  • Diagnostic Automation/Cortez Diagnostics Inc.

Segmentation Analysis of the Thyroid Function Test Market

By Test Type:

  • TSH
  • T3
  • T4
  • FT3
  • FT4

By End Use:

  • Clinics
  • Research Organizations
  • Diagnostic Laboratories
  • Hospitals

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Frequently Asked Questions

How big is the thyroid function test market?

The thyroid function test market is valued at US$ 1.75 billion in 2023.

What is the future scope of the thyroid function test market?

The thyroid function test market is set to expand by a CAGR of 4.2% by 2033.

How much valuation is projected for the thyroid function test market in 2033?

The thyroid function test industry is forecast to reach US$ 2.64 billion by 2033.

What is the growth rate of the TSH thyroid function test market?

The TSH thyroid function test market is expected to expand at a 2.3% CAGR by 2033.

Which companies hold a significant share of the market?

Danaher Corporation, DiaSorin, F. Hoffman-La Roche AG, Merck KGaA, Biomerieux and Abbott Laboratories hold a significant share of the thyroid function test market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Test type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test type, 2023 to 2033

        5.3.1. TSH

        5.3.2. T3

        5.3.3. T4

        5.3.4. FT3

        5.3.5. FT4

        5.3.6. Others

    5.4. Y-o-Y Growth Trend Analysis By Test type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Test type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033

        6.3.1. Clinics

        6.3.2. Research Organizations

        6.3.3. Diagnostic Laboratories

        6.3.4. Hospitals

    6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Test type

        8.2.3. By End Use

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Test type

        8.3.3. By End Use

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Test type

        9.2.3. By End Use

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test type

        9.3.3. By End Use

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Test type

        10.2.3. By End Use

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test type

        10.3.3. By End Use

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Test type

        11.2.3. By End Use

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test type

        11.3.3. By End Use

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Test type

        12.2.3. By End Use

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test type

        12.3.3. By End Use

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Test type

        13.2.3. By End Use

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test type

        13.3.3. By End Use

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Test type

        14.2.3. By End Use

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test type

        14.3.3. By End Use

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Test type

            15.1.2.2. By End Use

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Test type

            15.2.2.2. By End Use

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Test type

            15.3.2.2. By End Use

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Test type

            15.4.2.2. By End Use

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Test type

            15.5.2.2. By End Use

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Test type

            15.6.2.2. By End Use

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Test type

            15.7.2.2. By End Use

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Test type

            15.8.2.2. By End Use

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Test type

            15.9.2.2. By End Use

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Test type

            15.10.2.2. By End Use

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Test type

            15.11.2.2. By End Use

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Test type

            15.12.2.2. By End Use

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Test type

            15.13.2.2. By End Use

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Test type

            15.14.2.2. By End Use

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Test type

            15.15.2.2. By End Use

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Test type

            15.16.2.2. By End Use

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Test type

            15.17.2.2. By End Use

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Test type

            15.18.2.2. By End Use

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Test type

            15.19.2.2. By End Use

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Test type

            15.20.2.2. By End Use

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Test type

            15.21.2.2. By End Use

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Test type

            15.22.2.2. By End Use

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Test type

            15.23.2.2. By End Use

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Test type

        16.3.3. By End Use

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Danaher Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. DiaSorin

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. F. Hoffmann-La Roche AG

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Merck KGaA

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Biomerieux

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Abbott Laboratories

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

        17.1.7. ThermoFisher Scientific

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

        17.1.8. Qualigen Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

        17.1.9. KRONUS

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

        17.1.10. Diagnostic Automation/Cortez Diagnostics Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Hepatitis B Diagnostic Tests Market

Published : October 2023

Healthcare

Antigen Skin Test Market

Published : March 2023

Healthcare

Papillary Thyroid Cancer Market

Published : November 2022

Healthcare

Blood Culture Test Market

Published : October 2022

Explore Healthcare Insights

View Reports

Thyroid Function Test Market